Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis

European Journal of Human Genetics

Volumn 18, Issue 7, 2010, Pages 821-826

  Seddighzadeh, Maria ^a   Korotkova, Marina ^a   Källberg, Henrik ^b   Ding, Bo ^b   Daha, Nina ^c   Kurreeman, Fina A S ^c   Toes, Rene E M ^c   Huizinga, Tom W ^c   Catrina, Anca I ^a   Alfredsson, Lars ^b,d   Klareskog, Lars ^a   Padyukov, Leonid ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Stockholm Centre of Public Health   (Sweden)

Author keywords

Gene gene interaction; MHC class II; RA; Serotonin receptor

Indexed keywords

AUTOANTIBODY; EPITOPE; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; SEROTONIN 2A RECEPTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE INTERACTION; GENE REPLICATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOFLUORESCENCE TEST; JOINT BIOPSY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; RNA ANALYSIS; SWEDEN; UNITED STATES;

ADULT; ALLELES; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; CITRULLINE; CONFIDENCE INTERVALS; EPITOPES; FEMALE; GENE EXPRESSION REGULATION; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RECEPTOR, SEROTONIN, 5-HT2A; RNA, MESSENGER; SYNOVIAL MEMBRANE;

EID: 77953812193     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2010.12     Document Type: Article

References (37)

1. Stastny P: Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978; 298: 869-871.
2. Begovich AB, Carlton VE, Honigberg LA et al: A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330-337.
3. Remmers EF, Plenge RM, Lee AT et al: STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007; 357: 977-986.
4. Plenge RM, Seielstad M, Padyukov L et al: TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007; 357: 1199-1209.
5. Kurreeman FA, Padyukov L, Marques RB et al: A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 2007; 4: e278.
6. Raychaudhuri S, Remmers EF, Lee AT et al: Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40: 1216-1223.
7. Kallberg H, Padyukov L, Plenge RM et al: Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007; 80: 867-875.
8. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L: A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004; 50: 3085-3092.
9. Abdouh M, Storring JM, Riad M et al: Transcriptional mechanisms for induction of 5-HT1A receptor mRNA and protein in activated B and T lymphocytes. J Biol Chem 2001; 276: 4382-4388.
10. Sternberg EM, Trial J, Parker CW: Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists. J Immunol 1986; 137: 276-282.
11. Hoyer D, Hannon JP, Martin GR: Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002; 71: 533-554.
12. Idzko M, Panther E, Stratz C et al: The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol 2004; 172: 6011-6019.
13. Guillet-Deniau I, Burnol AF, Girard J: Identification and localization of a skeletal muscle secrotonin 5-HT2A receptor coupled to the Jak/STAT pathway. J Biol Chem 1997; 272: 14825-14829.
14. Cloez-Tayarani I, Petit-Bertron AF, Venters HD, Cavaillon JM: Differential effect of serotonin on cytokine production in lipopolysaccharide- stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors. Int Immunol 2003; 15: 233-240.
15. Yu B, Becnel J, Zerfaoui M, Rohatgi R, Boulares AH, Nichols CD: Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency. J Pharmacol Exp Ther 2008; 327: 316-323.
16. Kling A, Seddighzadeh M, Arlestig L, Alfredsson L, Rantapaa-Dahlqvist S, Padyukov L: Genetic variations in the serotonin 5-HT2A receptor gene (HTR2A) are associated with rheumatoid arthritis. Ann Rheum Dis 2008; 67: 1111-1115.
17. Plenge RM, Padyukov L, Remmers EF et al: Replication of putative candidate-gene associations with rheumatoid arthritis in 44,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005; 77: 1044-1060.
18. Mattey DL, Dawes PT, Clarke S et al: Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis. Arthritis Rheum 2002; 47: 403-407.
19. Klareskog L, Stolt P, Lundberg K et al: A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune r eactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54: 38-46.
20. van Oosterhout M, Bajema I, Levarht EW, Toes RE, Huizinga TW, van Laar JM: Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum 2008; 58: 53-60.
21. van Dongen H, van Aken J, Lard LR et al: Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007; 56: 1424-1432.
22. Arnett FC, Edworthy SM, Bloch DA et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
23. van Aken J, van Bilsen JH, Allaart CF, Huizinga TW, Breedveld FC: The Leiden Early Arthritis Clinic. Clin Exp Rheumatol 2003; 21: S100-S105.
24. Jawaheer D, Seldin MF, Amos CI et al: A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 2001; 68: 927-936.
25. Jawaheer D, Lum RF, Amos CI, Gregersen PK, Criswell LA: Clustering of disease features within 512 multicase rheumatoid arthritis families. Arthritis Rheum 2004; 50: 736-741.
26. Ronnelid J, Wick MC, Lampa J et al: Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 2005; 64: 1744-1749.
27. Huizinga TW, Amos CI, van der Helm-van Mil AH et al: Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005; 52: 3433-3438.
28. Ulfgren AK, Lindblad S, Klareskog L, Andersson J, Andersson U: Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54: 654-661.
29. Westman M, Korotkova M, af Klint E et al: Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium. Arthritis Rheum 2004; 50: 1774-1780.
30. Stephens M, Donnelly P: A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
31. Rothman K: Epidemiology. An Introduction. New York: Oxford University Press, 2002.
32. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A: Calculating measures of biological interaction. Eur J Epidemiol 2005; 20: 575-579.
33. Fleiss JL: The statistical basis of meta-analysis. Stat Methods Med Res 1993; 2: 121-145.
34. Norton N, Owen MJ: HTR2A: association and expression studies in neuropsychiatric genetics. Ann Med 2005; 37: 121-129.
35. Eaton WW, Hayward C, Ram R: Schizophrenia and rheumatoid arthritis: a review. Schizophr Res 1992; 6: 181-192.
36. Wright P, Donaldson PT, Underhill JA, Choudhuri K, Doherty DG, Murray RM: Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia. Am J Psychiatry 1996; 153: 1530-1533.
37. Sasaki T, Matsushita M, Nanko S, Fukuda R, Kennedy JL, Tokunaga K: Schizophrenia and the HLA-DRB1 gene in the Japanese population. Am J Psychiatry 1999; 156: 771-773.